• Yardeni Research expects no grand bargain from Thursday’s Trump-Xi meeting, but sees scope for a truce extension and selective deals.
  • Potential progress includes soybean purchases, Boeing (BA) orders, rare-earth access, fentanyl cooperation, and AI guardrails.
  • The toughest issues—Taiwan and AI dominance—are expected to remain unresolved.

A Summit of Incremental Steps

When President Trump and Chinese President Xi Jinping meet at the White House on Thursday, September 24, the most likely outcome is an incremental stabilization package—not a broad settlement—according to Yardeni Research. The firm expects the leaders to focus on extending the existing trade truce before its November 10 expiry, modest tariff relief, agriculture and aircraft purchases, rare-earth flows, and a new channel for AI-risk discussions. Taiwan, semiconductor/AI leadership, and deeper strategic rivalry are unlikely to be resolved.

Preparatory talks in New York involving U.S. Treasury Secretary Scott Bessent, U.S. Trade Representative Jamieson Greer, and Chinese Vice Premier He Lifeng laid the groundwork for continued negotiation. They announced plans to establish an AI dialogue and operationalize a bilateral trade body, creating a framework for engagement even if the summit yields only limited deliverables.

Truce Extension in Focus

The existing trade truce, agreed after the October 2025 Trump–Xi meeting in Busan, South Korea, is due to expire on November 10. Both sides have incentives to extend it, though they may differ on duration: Beijing reportedly prefers a longer détente, while Washington may favor a shorter renewal to retain leverage. Negotiators are discussing reciprocal tariff reductions affecting roughly $30 billion of goods, as well as agriculture and non-tariff barriers. China could most readily offer concessions through lower barriers or larger purchases of U.S. farm products.

Rare-earth access has become more urgent: China’s rare-earth magnet exports to the United States reportedly fell 21% in August from the prior month, to 512 metric tons. That reinforces U.S. concern over supply reliability before the meeting.

Boeing and Soybeans: Tangible Wins?

Boeing aircraft purchases and soybean purchases remain plausible commercial announcements. Reports describe earlier Chinese commitments involving increased U.S. agricultural buying and more than 200 Boeing aircraft, though a final summit agreement had not been confirmed as of the latest reporting. A Chinese aircraft-purchase announcement would be a politically visible export win for Washington and could signal an easing of trade friction, but it would not settle Boeing’s wider operational, certification, delivery, or competitive challenges. The ultimate economic effect would depend on aircraft type, order firmness, delivery timing, financing, and whether China’s regulators facilitate deliveries.

Strategic Rivalry Persists

The summit is taking place amid a managed but fragile rivalry. The prospective agenda combines cooperative issues—trade, fentanyl precursors, commercial purchases, and AI safety—with core disputes that neither leader is expected to concede. Taiwan remains the most consequential security flashpoint. It is unlikely to be resolved in a trade-focused meeting because it concerns sovereignty, military deterrence, and the broader U.S. alliance system. Semiconductors and advanced AI are similarly resistant to compromise. U.S. technology restrictions and China’s drive for technological self-sufficiency reflect national-security policy, industrial strategy, and military competition—not simply market-access disputes.

China’s rare-earth position appears to have changed the negotiating balance. Analysts cited by Reuters said Beijing’s leverage over materials vital to technology and auto manufacturing has encouraged a less confrontational U.S. tone ahead of the meeting. Fentanyl cooperation is a politically important area of possible limited progress. It allows both governments to demonstrate practical engagement on a public-health and law-enforcement problem without making strategic concessions on Taiwan or advanced technology.

Market Implications

Investors are watching primarily for a truce extension and any details on tariff cuts, Boeing orders, agricultural purchases, and rare-earth supply commitments. The market-sensitive distinction is between a temporary de-escalation and a durable reordering of U.S.–China economic relations; current signals point toward the former. An extension of the truce would reduce the immediate risk of a new tariff escalation, helping importers, manufacturers, retailers, farmers, and consumers by limiting abrupt cost increases and supply-chain disruption. Conversely, a failed summit could raise the likelihood of renewed tariffs after November 10.

U.S. farmers could benefit from new Chinese purchase commitments. Boeing and aerospace suppliers could benefit from an aircraft deal, though implementation is crucial. U.S. and allied manufacturers would benefit from more predictable rare-earth supply, while remaining exposed to China concentration risk. Technology firms may welcome reduced escalation but are unlikely to see a quick rollback of strategic technology controls.

What Would Count as Success

A clearly dated extension of the truce beyond November 10, a credible commitment to restore or increase rare-earth and magnet flows, specific tariff reductions or non-tariff-barrier measures, verifiable soybean or broader agricultural-purchase commitments, an aircraft agreement with identifiable scope and delivery terms, and a continuing AI dialogue with concrete safety procedures—potentially including incident-notification discussions—would all represent tangible progress. A “grand bargain” on semiconductors, currency policy, Taiwan, AI leadership, or comprehensive trade restructuring remains unlikely. One recent market analysis explicitly characterized expectations as limited and said a broad bargain is unlikely.

The most realistic long-term implication is continued “competitive coexistence”: periodic agreements to limit economic damage, alongside persistent rivalry over technology, supply chains, military power, and regional influence. The key test will be whether any Thursday announcements survive beyond the next truce deadline and are implemented in trade flows, export licenses, agricultural purchases, and regulatory practice.

Correction: An earlier version misstated the date of the Trump-Xi meeting. It is scheduled for Thursday, September 24, not September 23.